Growth Metrics

DBV Technologies (DBVT) Assets Average (2015 - 2026)

DBV Technologies (DBVT) reported Assets Average of $250.0 million for Q1 2026, up 330.3% year-over-year from $58.1 million in Q1 2025, and up 45.3% on a QoQ basis from $172.1 million in Q4 2025.

DBV Technologies (DBVT) has 11 years of Assets Average data on file, last reported at $250.0 million in Q1 2026.

  • Quarterly Assets Average rose 330.3% year-over-year to $250.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $250.0 million (up 330.3% YoY) and the FY2025 annual result came in at $149.7 million, up 20.4% from the prior year.
  • Assets Average climbed to $250.0 million in Q1 2026 per DBVT's latest filing, from $172.1 million in the prior quarter.
  • Across five years, Assets Average topped out at $266.5 million in Q3 2022 and bottomed at $58.1 million in Q1 2025.
  • The 5-year median for Assets Average is $172.1 million (2025), against an average of $169.6 million.
  • The widest annual swing landed in 2025, when Assets Average plunged 64.66%; it then surged 330.3% in 2026.
  • Tracing DBVT's Assets Average over 5 years: stood at $247.3 million in 2022, then fell by 24.64% to $186.4 million in 2023, then sank by 57.42% to $79.4 million in 2024, then surged by 116.87% to $172.1 million in 2025, then surged by 45.3% to $250.0 million in 2026.
  • Per Business Quant, the three latest DBVT Assets Average figures stand at $250.0 million (Q1 2026), $172.1 million (Q4 2025), and $127.0 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 13.04 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - 33.42 Mn
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 1.72 Bn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - 331.70 Mn
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 40.89 Mn
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 26.06 Bn
7 Evaxion A 62.56 Bn 62.54 Bn - 26.03 Mn
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn 40.71 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 5.05 Bn
10 DBV Technologies 8.00 Bn 7.77 Bn -3.90 Mn 250.05 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 250.05 Mn
Dec 31, 2025 172.10 Mn
Sep 30, 2025 126.96 Mn
Jun 30, 2025 97.00 Mn
Mar 31, 2025 58.11 Mn
Dec 31, 2024 79.36 Mn
Sep 30, 2024 103.62 Mn
Jun 30, 2024 130.04 Mn
Mar 31, 2024 164.44 Mn
Dec 31, 2023 186.38 Mn
Sep 30, 2023 203.65 Mn
Jun 30, 2023 225.22 Mn
Mar 31, 2023 239.72 Mn
Dec 31, 2022 247.32 Mn
Sep 30, 2022 266.55 Mn
Jun 30, 2022 201.28 Mn
Mar 31, 2022 132.15 Mn
Dec 31, 2021 158.82 Mn
Sep 30, 2021 185.75 Mn
Jun 30, 2021 210.99 Mn
Mar 31, 2021 246.83 Mn
Dec 31, 2019 219.48 Mn
Sep 30, 2019 190.71 Mn
Jun 30, 2019 202.89 Mn
Jun 30, 2018 254.02 Mn
Dec 31, 2017 235.47 Mn
Jun 30, 2017 286.01 Mn
Dec 31, 2016 340.54 Mn
Jun 30, 2016 373.47 Mn
Dec 31, 2015 253.90 Mn
Jun 30, 2015 144.13 Mn